Goldman Sachs asks in biotech research report: 'Is curing patients a sustainable business model?'

[patphil]

21. Is curing patients a sustainable business model?

I worked for a Pharmaceutical company for 36 years, and I will always remember what one of the company VP's said to us at a Quality Control/Quality Assurance meeting.
He said that the company was more interested in a medicine that provide the patient with an acceptable quality of life, and not necessarily a cure.
He said that if you cure/heal a patient, you lose a customer.
Imagine if, for instance, you could take a tablet for a month and be cured, as opposed to taking a similar medication for life to control the symptoms. It's the difference between perhaps 50-100 dollars as opposed to thousands of dollars.

This is their philosophy. Greed Over People.